Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →
KW-6356 research product
Shipping batch339DRView certificate

Neurocognitive Research

KW-6356

397.4 g/mol

KW-6356 is a rare liquid research compound. Each 30ML bottle holds 5MG per mL, or 150MG in total. Labs use it to study the adenosine A2A receptor. A second focus is how this receptor works with the dopamine system. Other topics include motor pathway signaling and CNS receptor selectivity.

In stock · ready to shipEarn 84 points
Quantity
1
$84.99
Save 10% with code WELCOME10 at checkout
Your purchasing batch
339DR
Certificate on record for this lot

Bundle & save

COA
Referral program · researchers save 10%, you earn 15% back
FedEx 2-Day shipping
Free on orders over $250
Ships from the US West Coast
Tracked delivery on every order
Per-batch COA access
Every order ships with certificate access for its lot
Secure encrypted checkout CASH APP 5% OFFZELLE 5% OFFBANK TRANSFER 5% OFFCHIME 5% OFFCRYPTO 7% OFFVISA · AMEX NO FEE

More ways to save

Up to20%OFF

Bulk Orders 20+ bottles

Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.

Ask about bulk

Shipping batch 339DR

Open the certificate matched to this shipping batch.

View certificate ↗

Verified test results

Every batch, independently verified.

Each batch is analyzed by Chromate, an independent third-party laboratory, before release. Below is the report for lot 339DR, summarized from the certificate the lab published.

CHR
Chromate
Independent third-party laboratory
PASS
Certificate of Analysis · #38848
Lot
339DR
Tested
Aug 29, 2026
Measured
5.139mg/mL
Independent third-party lab
MethodQualitative and quantitative chemical analysis by RP-HPLC with UV detection
IssuedAug 29, 2026 · signed by the principal chemist
VerifyAccess code printed on the certificate, checked at chromate.org/verify
KW-6356 certificate of analysisOpen the 339DR certificate
View the signed certificate →
Certificate results✓ 2 passed · 1 reported
Appearance
Per certificate
Clear liquid
PASS
Identity
HPLC
KW-6356
PASS
Net content
HPLC
5.139mg/mL
5MG/ML
REPORTED

Every batch on record

This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.

Open the COA portal →

Side by side

How Disguised compares.

Disguised
Typical supplier
Per-batch third-party COA
Yes
Rarely provided
Independent third-party testing
Yes
Inconsistent
HPLC purity verified
Yes
Often unverified
Made & tested in the USA
Yes
Often overseas
Discreet, tracked shipping
Yes
Varies

Technical specifications

Compound Information

Read the KW-6356 research guide
Molecular Profile

What is KW-6356?

Molecular FormulaC₂₀H₁₉N₃O₄S
Molecular Weight397.4g/mol
Storage Requirements

Stability information.

Do not freezeProtect from lightKeep the vial closed
2–8°C
Refrigerate after opening
Refrigerate once the seal is broken and keep it protected from light.
15–25°C
Unopened, as shipped
Room temperature is acceptable before opening. Do not freeze.

Important research notice

Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.

All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.

By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.

Ready when you are

Nothing ships without paperwork. Every lot is on record.

The lot on this page links to the signed certificate for that batch.

1Lot on record
1Independent lab
Loading...
✓
View Full Product Description
Made in USAManufacturing originGMP CertifiedManufacturing standard

Liquid research preparation

KW-6356: product details and research reference

KW-6356 is a rare liquid research compound. Each 30ML bottle holds 5MG per mL, or 150MG in total. Labs use it to study the adenosine A2A receptor. A second focus is how this receptor works with the dopamine system. Other topics include motor pathway signaling and CNS receptor selectivity.

It is not a common catalog item. We supply it as a finished liquid. Each batch gets an in-house QA check, and our own team ships every order.

Product details

CompoundKW-6356 (also written KW6356)
Strength5MG/ML
Volume30ML
Total content150MG
Formatfinished liquid
Molecular weight397.4 g/mol

What is KW-6356?

KW-6356 is a synthetic small molecule, not a peptide. Its generic name (INN) is sipagladenant. It acts at the A2A receptor in two ways. First, it blocks adenosine from binding. Second, it lowers the receptor's own built-in (constitutive) activity. So its developers call it an A2A antagonist and inverse agonist (Ohno et al., 2023).

In lab binding tests, it bound the human form of this receptor tightly and selectively. It also came off the receptor very slowly (Ohno et al., 2023). Our KW-6356 research guide lists more studies and their sources.

Our quality process

Rare liquids need more care than common capsules or powders. Strength, the carrier liquid, labels, records and storage all matter. Before release, we check each batch for:

  • A consistent formula
  • A clear strength label
  • How the bottle looks
  • Product records
  • In-house QA sign-off

Certificates for published lots are in our COA portal.

Verify our labs

You should be able to check the standards we describe. Learn more about the outside labs we work with: ILS Labs and Chromate.

Documentation and research handling

Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.

Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.

Product questions

How do concentration and total content differ?

Concentration is the stated amount per mL; total content also depends on the container volume. A per-spray amount requires a verified pump output and must not be inferred from concentration alone. Check each component separately for a blend.

Where is the batch-specific evidence?

Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.

Questions about KW-6356

Is KW-6356 an antagonist or an inverse agonist?

Both, in its developer's words: Kyowa Kirin describes it as an adenosine A2A receptor antagonist/inverse agonist, meaning it blocks adenosine binding and also inhibits the receptor's constitutive activity. In vitro it bound the human A2A receptor with sub-nanomolar affinity, dissociated very slowly and showed insurmountable antagonism.

How is KW-6356 different from istradefylline?

They come from the same company, now Kyowa Kirin, and both target the adenosine A2A receptor. Istradefylline is an alkylxanthine that behaved as a surmountable antagonist in vitro, while KW-6356 is a thiazole that showed insurmountable antagonism and inverse agonism; co-crystal structures tied its inverse agonism to contacts with His250 and Trp246. Istradefylline was FDA approved in 2019 as Nourianz.

Has KW-6356 been tested in clinical trials?

Yes, as research history. Kyowa Kirin ran two phase 1 studies in healthy Japanese and White volunteers, with randomized, double-blind, placebo-controlled and open-label parts, that measured its pharmacokinetics, and a double-blind, placebo-controlled phase 2 trial in Japan that randomized and treated 168 people with early, untreated Parkinson's disease and measured change in MDS-UPDRS Part III scores over 12 weeks.

Is KW-6356 FDA approved?

No. Drugs@FDA lists no product under KW-6356 or its nonproprietary name, sipagladenant. Kyowa Kirin, which discovered it, announced on 15 July 2022 that it was discontinuing the clinical development program, citing the global regulatory landscape, development hurdles and timelines for potential market entry, and a 2023 review lists it as no longer in development for Parkinson's disease.

View Currently Shipping CoA

The current certificate is matched to the selected product option and assigned shipping batch.

Enable JavaScript to view the certificate for your selected option.